
BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp.(BGLC)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · BGLC · 截至 Jun 9, 2026
关键指标
探索 BioNexus Gene Lab Corp. 数据
bglc stock data · financials财务快照
完整财报竞争对手与同行
bglc competitors股票表现
完整历史关于 BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., spec…
what is bionexus gene lab corp. · bglc stock overview · bionexus gene lab corp. company profile · who is bionexus gene lab corp. ceo · bglc NASDAQ · bionexus gene lab corp. headquarters · bionexus gene lab corp. business segments
关于股票概览与关键数据
BioNexus Gene Lab Corp.(BGLC)是 Medical - Diagnostics & Research 行业的 Healthcare 类公司,于 Jan 8, 2021 在 NASDAQ 上市。截至最近交易日,BGLC 股价为 $2.19,市值约为 $4.4M。过去12个月累计回报 -28.66%,年初至今回报 -44.56%。
2025 财年 BioNexus Gene Lab Corp. 营收 $7.4M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,BioNexus Gene Lab Corp.(BGLC)股价为 $2.19,在 NASDAQ 上市,52周区间为 $1.92 – $15.60。